MedPath

National Cancer Center Korea

National Cancer Center Korea logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1989-01-01
Employees
-
Market Cap
-
Website
http://www.ncc.re.kr

ICG-coated Endoscopic Clip for Tumor Localization

Not Applicable
Completed
Conditions
Colorectal Neoplasms
First Posted Date
2019-04-23
Last Posted Date
2019-11-27
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
30
Registration Number
NCT03924349
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)

Phase 2
Conditions
Early Gastric Cancer
First Posted Date
2019-02-12
Last Posted Date
2019-02-12
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
88
Registration Number
NCT03837301
Locations
🇰🇷

National Cancer Center, Goyang, Korea, Republic of

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

Phase 2
Conditions
Non-small Cell Lung Cancer
Interventions
Drug: CA and Nivolumab
First Posted Date
2019-01-17
Last Posted Date
2022-04-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
22
Registration Number
NCT03808480
Locations
🇰🇷

National Cancer Center, Goyang-Si, Gyeonggi-do, Korea, Republic of

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 2
Active, not recruiting
Conditions
Triple Negative Breast Cancer
Interventions
First Posted Date
2018-11-28
Last Posted Date
2023-11-09
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
284
Registration Number
NCT03756298
Locations
🇰🇷

Korea University, Guro hospital, Seoul, Korea, Republic of

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Phase 2
Conditions
HER2-positive Breast Cancer
Metastatic Breast Cancer
Interventions
First Posted Date
2018-11-27
Last Posted Date
2021-03-11
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
119
Registration Number
NCT03755141
Locations
🇰🇷

Korea University, Guro hospital, Seoul, Korea, Republic of

Study of Lorlatinib in ROS1 Rearranged NSCLC

Phase 2
Conditions
Nonsmall Cell Lung Cancer
Interventions
First Posted Date
2018-08-02
Last Posted Date
2022-04-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
35
Registration Number
NCT03612154
Locations
🇰🇷

National Cancer Center, Goyang-Si, Gyeonggi-do, Korea, Republic of

Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer

Not Applicable
Recruiting
Conditions
Colorectal Cancer
First Posted Date
2018-07-05
Last Posted Date
2019-08-21
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
30
Registration Number
NCT03577665
Locations
🇰🇷

National Cancer Center Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer

Not Applicable
Recruiting
Conditions
Colorectal Cancer
First Posted Date
2018-06-25
Last Posted Date
2019-08-21
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
36
Registration Number
NCT03566355
Locations
🇰🇷

National Cancer Center Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer

Phase 2
Conditions
Breast Cancer
Invasive Breast Cancer
Interventions
First Posted Date
2018-04-13
Last Posted Date
2018-04-13
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
114
Registration Number
NCT03497702
Locations
🇰🇷

National Cancer Center, Goyang-si, Korea, Republic of

Korean Lung Cancer Screening Project

Conditions
Lung Cancer
First Posted Date
2018-01-09
Last Posted Date
2018-01-09
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
8000
Registration Number
NCT03394703
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath